ACAPODENE

DEAD

Serial Number

76548599

Owner

GTX, INC.

Attorney

Grady M. Garrison

First Use Date

Nov 1, 2004

Filing Date

Oct 2, 2003

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ACAPODENE Trademark

Serial Number: 76548599 • Registration: 2926770

ACAPODENE is a trademark filed by GTX, INC. on October 2, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

GTX, INC. (22 trademarks)

3 NORTH DUNLAP AVENUE
MEMPHIS, TN 38163

Entity Type: 03

Legal Representation

Attorney of Record

Grady M. Garrison

981 trademarks filed View all →

Trademark Details

Filing Date

October 2, 2003

Registration Date

February 15, 2005

First Use Anywhere

November 1, 2004

First Use in Commerce

November 1, 2004

Published for Opposition

June 8, 2004

Cancellation Date

September 18, 2015

Goods & Services

Pharmaceutical preparations and compounds for use in connection with the treatment of precancerous lesions of the prostate to prevent prostate cancer and the prevention and treatment of prostate cancer and pharmaceutical preparations for use in connection with the treatment of the side effects of prostate cancer therapy

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Sep 18, 2015 CAEX

REGISTERED - SEC. 7 REQUEST ABANDONED

Dec 18, 2010 PRA7

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 18, 2010 APRE

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 21, 2009 ASGN

POST REGISTRATION ACTION MAILED - SEC. 7

Jul 24, 2008 PRAM

ASSIGNED TO PARALEGAL

Jul 23, 2008 PLGL

TEAS SECTION 7 REQUEST RECEIVED

Jun 30, 2008 ES7R

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 27, 2007 TCCA

REGISTERED-PRINCIPAL REGISTER

Feb 15, 2005 R.PR

LAW OFFICE REGISTRATION REVIEW COMPLETED

Dec 15, 2004 REGV

ASSIGNED TO LIE

Dec 13, 2004 ALIE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 3, 2004 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Nov 29, 2004 SUPC

USE AMENDMENT FILED

Nov 11, 2004 IUAF

TEAS STATEMENT OF USE RECEIVED

Nov 11, 2004 EISU

NOA MAILED - SOU REQUIRED FROM APPLICANT

Aug 31, 2004 NOAM

PUBLISHED FOR OPPOSITION

Jun 8, 2004 PUBO

NOTICE OF PUBLICATION

May 19, 2004 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 24, 2004 CNSA

ASSIGNED TO EXAMINER

Mar 22, 2004 DOCK

Related Trademarks

More from this Owner

OSTARINE

GTX

More in Same Class

VALEANT

TRANSFORM PHARMACEUTICALS

DERMAX

BIO-ALTERNATIVES

PHEROMONOTHERAPY

Serial #78308693